Health TrialsbyHealthPanel

Systemic Sclerosis in Adults

2

Review clinical trials related to Systemic Sclerosis in Adults. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Obinutuzumab in Systemic Sclerosis

The purpose of this study is to determine if obinutuzumab is effective in systemic sclerosis

Participants needed: 120
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Assistance Publique - Hôpitaux de ParisUpdated: Sep 25, 2026Locations: 1
Eligibility criteria

Adult patient (>/= 18 years old), [+7]

Any B-cell depleting (e.g., anti-CD20, anti-CD19) or anti-plasma cell therapy su... [+27]

Read more
Status: Not yet recruiting

Rituximab vs Placebo for Maintenance in Systemic Sclerosis - Interstitial Lung Disease

The purpose of this study is to determine whether Rituximab is safe and effective as a maintenance strategy in individuals with stabilized systemic sclerosis in adults.

Participants needed: 120
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Assistance Publique - Hôpitaux de ParisUpdated: Sep 18, 2026Locations: 1
Eligibility criteria

Adult patient (≥ 18 years old), [+8]

Forced vital capacity < 40% of the predicted value [+26]

Read more